There is limited safety of probiotics in the critically ill patient. Typical side effects are sepsis, fungemia, and even bowel ischemia. Nevertheless, the administration of pro- and prebiotics (synbiotics) is a promising concept with possible impact on the incidence of ventilator-associated pneumonia, infectious complications, and diarrhea. The most appropriate species has not been elucidated yet.